ESR1 mutations affect anti-proliferative responses to tamoxifen through enhanced cross-talk with IGF signaling
Breast Cancer Research and Treatment (2016) - Comments
pubmed: 27178332  doi: 10.1007/s10549-016-3829-5  issn: 1573-7217  issn: 0167-6806 

Luca Gelsomino, Guowei Gu, Yassine Rechoum, Amanda R. Beyer, Sasha M. Pejerrey, Anna Tsimelzon, Tao Wang, Kenneth Huffman, Andrew Ludlow, Sebastiano Andò, Suzanne A. W. Fuqua